Umer Raffat's Stock Ratings

Evercore ISI Group Analyst

Umer Raffat is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025

Overall Average Return

-8.46%

Smart Score

45.1%

Overall Average Return Percentile

22nd

Number of Ratings

24
Buy NowGet Alert
02/25/2025MTSRBuy Now
Metsera
$27.66—
Umer Raffat45%
—Initiates → OutperformGet Alert
07/16/2024SYREBuy Now
Spyre Therapeutics
$15.08—
Umer Raffat45%
—Initiates → OutperformGet Alert
03/08/2024AMLXBuy Now
Amylyx Pharma
$5.10—
Umer Raffat45%
—DowngradeOutperform → In-LineGet Alert
02/28/2024GUTSBuy Now
Fractyl Health
$1.95—
Umer Raffat45%
—Initiates → OutperformGet Alert
02/16/2024RAPTBuy Now
RAPT Therapeutics
$7.19—
Umer Raffat45%
—Initiates → OutperformGet Alert
10/24/2023ALKSBuy Now
Alkermes
$29.41—
Umer Raffat45%
—UpgradeIn-Line → OutperformGet Alert
06/21/2023CNTABuy Now
Centessa Pharmaceuticals
$12.68—
Umer Raffat45%
—Initiates → OutperformGet Alert
05/18/2023TEVABuy Now
Teva Pharmaceutical Indus
$17.06—
Umer Raffat45%
—UpgradeIn-Line → OutperformGet Alert
05/11/2023PHATBuy Now
Phathom Pharmaceuticals
$10.80—
Umer Raffat45%
—UpgradeIn-Line → OutperformGet Alert
03/07/2023MLYSBuy Now
Mineralys Therapeutics
$13.73—
Umer Raffat45%
—Initiates → OutperformGet Alert
11/02/2022LEGNBuy Now
Legend Biotech
$35.20—
Umer Raffat45%
—Initiates → OutperformGet Alert
09/13/2022CEREBuy Now
Cerevel Therapeutics Hldg
——
Umer Raffat45%
—Initiates → OutperformGet Alert
05/06/2022PHATBuy Now
Phathom Pharmaceuticals
$10.80—
Umer Raffat45%
—DowngradeOutperform → In-LineGet Alert
02/02/2022AMLXBuy Now
Amylyx Pharma
$5.10—
Umer Raffat45%
—Initiates → OutperformGet Alert
06/10/2021OGNBuy Now
Organon
$9.83—
Umer Raffat45%
—Initiates → OutperformGet Alert
03/12/2021KODBuy Now
Kodiak Sciences
$3.53—
Umer Raffat45%
—Initiates → OutperformGet Alert
03/03/2021VORBuy Now
Vor Biopharma
$0.2221718.18%
Umer Raffat45%
→ $48Initiates → OutperformGet Alert
01/21/2020AMGNBuy Now
Amgen
$289.00—
Umer Raffat45%
—UpgradeIn-Line → OutperformGet Alert
11/20/2019PHATBuy Now
Phathom Pharmaceuticals
$10.80—
Umer Raffat45%
—Initiates → OutperformGet Alert
01/28/2019AMGNBuy Now
Amgen
$289.00—
Umer Raffat45%
—DowngradeOutperform → In-LineGet Alert
03/19/2018PIRSBuy Now
Pieris Pharmaceuticals
——
Umer Raffat45%
→ $13Initiates → OutperformGet Alert
01/16/2018DRNABuy Now
Dicerna Pharmaceuticals
——
Umer Raffat45%
→ $14Initiates → OutperformGet Alert
06/30/2017DERMBuy Now
Journey Medical
$6.35655.91%
Umer Raffat45%
→ $48Initiates → OutperformGet Alert
02/23/2017JAZZBuy Now
Jazz Pharmaceuticals
$108.24—
Umer Raffat45%
—Initiates → BuyGet Alert